The novel histone deacetylase inhibitor NVP-LAQ824: an addition to the therapeutic armamentarium in leukemia?

被引：7
|
作者：
Grant, S
机构：
[1] Virginia Commonwealth Univ, Dept Med, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Dept Biochem, Richmond, VA 23298 USA
[3] Virginia Commonwealth Univ, Dept Pharmacol, Richmond, VA 23298 USA
来源：
LEUKEMIA | 2004年 / 18卷 / 12期
关键词：
D O I：
10.1038/sj.leu.2403522
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1931 / 1933
页数：3
相关论文
共 50 条
  • [21] Synergistic interactions between the HDAC inhibitor NVP-LAQ824 and the nucleoside analog fludarabine in human leukemia cells involve ROS generation and modulation of the NF-kB and JNK pathways
    Rosato, Roberto R.
    Maggio, Sonia C.
    Almenara, Jorge A.
    Coe, Stefanie
    Rahmani, Mohamed
    Dai, Yun
    Atadja, Peter
    Grant, Steven
    CANCER RESEARCH, 2006, 66 (08)
  • [22] Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of a novel histone deacetylase inhibitor, LAQ824, in human colon carcinoma cells and xenografts
    Chung, Yuen-Li
    Troy, Helen
    Kristeleit, Rebecca
    Aherne, Wynne
    Jackson, Elizabeth
    Atadja, Peter
    Griffiths, John R.
    Judson, Ian R.
    Workman, Paul
    Leach, Martin O.
    Beloueche-Babari, Mounia
    NEOPLASIA, 2008, 10 (04): : 303 - 313
  • [23] The histone deacetylase inhibitor LAQ824 is selectively toxic to tumor cell lines including multidrug resistant cells
    Atadja, P
    Remiszewski, L
    Trogani, N
    Walker, H
    Hsu, M
    Gao, L
    Yeleswarapu, L
    Perez, L
    Cohen, P
    Lassota, P
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S103 - S103
  • [24] Histone Deacetylase Inhibitor LAQ824 Augments Inflammatory Responses in Macrophages through Transcriptional Regulation of IL-10
    Wang, Hongwei
    Cheng, Fengdong
    Woan, Karrune
    Sahakian, Eva
    Merino, Oscar
    Rock-Klotz, Jennifer
    Vicente-Suarez, Ildefonso
    Pinilla-Ibarz, Javier
    Wright, Kenneth L.
    Seto, Edward
    Bhalla, Kapil
    Villagra, Alejandro
    Sotomayor, Eduardo M.
    JOURNAL OF IMMUNOLOGY, 2011, 186 (07): : 3986 - 3996
  • [25] A phase I, pharmacokinetic (PK) and pharmacodynamic (PD) study of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors
    Rowinsky, EK
    Pacey, S
    Patnaik, A
    O'Donnell, A
    Mita, MM
    Atadja, P
    Peng, B
    Dugan, M
    Scott, JW
    De Bono, JS
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 200S - 200S
  • [26] Cardiac monitoring in phase I trials of a novel histone deacetylase (HDAC) inhibitor LAQ824 in patients with advanced solid tumors and hematologic malignancies
    Rowinsky, EK
    de Bono, J
    Deangelo, DJ
    van Oosterom, A
    Morganroth, J
    Laird, GH
    Dugan, M
    Scott, JW
    Ottmann, OG
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 224S - 224S
  • [27] The deacetylase inhibitor LAQ824 induces notch signalling in haematopoietic progenitor cells
    Schwarz, Kerstin
    Romanski, Annette
    Puccetti, Elena
    Wietbrauk, Sarah
    Vogel, Anja
    Keller, Maren
    Scott, Jeffrey W.
    Serve, Hubert
    Bug, Gesine
    LEUKEMIA RESEARCH, 2011, 35 (01) : 119 - 125
  • [28] Role of histone deacetylase inhibitor-induced reactive oxygen species and DNA damage in LAQ-824/fludarabine antileukemic interactions
    Rosato, Roberto R.
    Almenara, Jorge A.
    Maggio, Sonia C.
    Coe, Stefanie
    Atadja, Peter
    Dent, Paul
    Grant, Steven
    MOLECULAR CANCER THERAPEUTICS, 2008, 7 (10) : 3285 - 3297
  • [29] LAQ824 is a novel histone deacetylase inhibitor with significant activity against multiple myeloma:: Results of a pre-clinical evaluation in vitro and in vivo.
    Catley, L
    Weisberg, E
    Tai, YT
    Lin, B
    Mitsiades, N
    Hideshima, T
    LeBlanc, R
    Shringapure, R
    Burger, R
    Mitsiades, C
    Chauhan, D
    Schlossman, R
    Munshi, N
    Richardson, P
    Griffin, J
    Anderson, K
    BLOOD, 2002, 100 (11) : 106A - 106A
  • [30] Enhanced Antitumor Activity Induced by Adoptive T-Cell Transfer and Adjunctive Use of the Histone Deacetylase Inhibitor LAQ824
    Vo, Dan D.
    Prins, Robert M.
    Begley, Jonathan L.
    Donahue, Timothy R.
    Morris, Lilah F.
    Bruhn, Kevin W.
    de la Rocha, Pilar
    Yang, Meng-Yin
    Mok, Stephen
    Garban, Hermes J.
    Craft, Noah
    Economou, James S.
    Marincola, Francesco M.
    Wang, Ena
    Ribas, Antoni
    CANCER RESEARCH, 2009, 69 (22) : 8693 - 8699
12345